Cite
MLA Citation
L. Faulkner et al.. “PB1998: WEEKLY OPPOSED TO BI-WEEKLY BORTEZOMIB AS PART OF INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA IS BETTER TOLERATED AND EQUALLY EFFICIENT: REAL-WORLD DATA FROM A RETROSPECTIVE AUDIT.” HemaSphere, vol. 6, n.d., pp. 1869–1870. http://access.bl.uk/ark:/81055/vdc_100158014008.0x000038